Apnimed (APMD) vs Attovia Therapeutics (ATTO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Apnimed is the larger company by market cap ($751.0 million vs $749.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APMD | ATTO |
|---|---|---|
| Share price | $18.04 | $16.42 |
| Market cap | $751.02M | $749.59M |
| 1-day change | -3.27% | -6.17% |
| P/E ratio (TTM) | 2.59 | — |
| EPS (TTM) | $6.96 | $-2.56 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $35.29 | $28.00 |
| 52-week low | $16.12 | $16.15 |
| Distance from 52-week high | -48.88% | -41.36% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +178.99% | +157.00% |
| Average volume | 558.59K | 456.94K |
| Shares outstanding | 41.63M | 45.65M |
| Employees | 81 | 44 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Apnimed
APMD stock →Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets.
Healthcare · Biotechnology · 81 employees
About Attovia Therapeutics
ATTO stock →Attovia Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops biotherapeutics for immune-mediated diseases in the United States. The company provides ATTOBODY, a biparatopic biologics platform designed to deliver improved treatments.
Healthcare · Biotechnology · 44 employees
APMD vs ATTO FAQ
Which is bigger, Apnimed or Attovia Therapeutics?
Apnimed (APMD) is larger, with a market capitalization of $751.02M compared with $749.59M for Attovia Therapeutics (ATTO).
Are Apnimed and Attovia Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.